Sorrento Provides A New Way To Treat Pain [Seeking Alpha]
Sorrento Therapeutics, Inc. (SRNE)
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm
Check Earnings Report
US:NASDAQ Investor Relations:
sorrentotherapeutics.com/investors
Company Research
Source: Seeking Alpha
Sorrento Provides A New Way To Treat Pain Summary Sorrento Therapeutics announced positive results from its phase 1b study using RTX to treat patients with osteoarthritis of the knee. RTX is also being used to treat patients with terminal cancer pain. Sorrento has cash of $135.4 million as of Sept. 30, 2018, and along with the 5-year term loan, it can fund its operations for at least another 2 years. SRNE announced positive phase 1b results Phase 1b Data The phase 1b study was known as PTVA-OA-001, and it recruited patients with moderate to severe osteoarthritis of the knee. This first study was necessary in that it was used to assess the maximum tolerated dose (MTD) that could be used for future studies. It also looked at safety and preliminary efficacy of RTX in patients with Osteoarthritis of the Knee. The efficacy of this trial was established using something known as the WOMAC index Alternate Market Opportunity RTX being used to treat Osteoarthritis of the Knee is just one indica
Show less
Read more
Impact Snapshot
Event Time:
SRNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRNE alerts
High impacting Sorrento Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics